Middle East and Africa In-Vitro Diagnostics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product and Services (Reagents and Kits, Instruments, and Software and Services); Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others); Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others); End User (Hospitals, Laboratories, Homecare, and Others)

Publication Month: May 2021 | Report Code: TIPRE00022124 | No. of Pages: 202 | Category: Medical Device | Status: Published

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The In-vitro diagnostics market in Middle East and Africa is expected to grow from US$ 2,675.1 million in 2019 to US$ 3,454.0 million by 2027; it is estimated to grow at a CAGR of 3.2% from 2020 to 2027.

Automation deals with the utilization of various intelligent systems with an aim to perform any operation with minimal human intervention. The application of automation in clinical laboratories enables analysts to perform several tests in minimum turnaround time and efforts. Moreover, the automation can serve maximum accuracy in results as well as reduction in variations. Additionally, installation of intelligent software & hardware in clinical analyzers has dramatically improved the overall operating capacity, quality of data processing, and process control in clinical automation. Extensively increasing patient pool is generating massive demand for clinical automation as it offers superior benefits. For instance, in May 2019, Beckman Coulter, one of the major market players announced introduction of its new DxA 5000 total laboratory automation solution. The newly launched system is capable of managing high volume samples with significant reduction in procedural time. Furthermore, growing emphasis of healthcare institutes on cost and time optimization is fueling the adoption of automation in clinical laboratories. Additionally, increasing focus on error reduction, efficient sample collection, and patient safety would eventually boost the acceptance of laboratory automation during the forecast period.

 

The countries in the Middle East and African region have taken precautionary measures and imposed stringent regulations to control the spread of COVID-19. Countries such as UAE, Saudi Arabia, Jordan, Iraq, and Iran, have strictly imposed lockdown in the countries. The majority of the countries in the region are dependent on the other region for medical devices and other products. Therefore, there has been a shortage of various test kits in some countries. However, various international organizations such as International Federation for Red Cross, Red Crescent, and the United Nations Volunteers (UNV) program have helped in a great way to provide IVD facilities in all possible ways. Various European companies have been supporting by offering their rapid immunochemistry test. The import of rapid test kits has increased growth opportunities for various companies to expand their business in the region. Also, the growing developments for the healthcare industry in the region are likely to foster growth in the following years.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the In-vitro diagnostics market. The Middle East and Africa In-vitro diagnostics market is expected to grow at a good CAGR during the forecast period.

Get more information on this report :

 

Middle East and Africa In-Vitro Diagnostics Market Segmentation      

By Product and Services

  • Instruments
  • Reagents & Kits
  • Software & Services

By Technology

  • Immunoassay/ Immunochemistry
  • Clinical Chemistry
  • Molecular Diagnostics
  • Microbiology
  • Blood Glucose Self-Monitoring
  • Coagulation & Hemostasis
  • Hematology
  • Urinalysis
  • Others

By Application

  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Autoimmune Diseases
  • Nephrology
  • Others

By End User

  • Hospitals
  • Laboratories
  • Homecare
  • Others

By Country

  • Middle East and Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of Middle East and Africa

Companies Mentioned

  • F. HOFFMANN-LA ROCHE LTD.
  • DANAHER
  • ABBOTT
  • SIEMENS AG
  • SYSMEX CORPORATION
  • THERMO FISHER SCIENTIFIC, INC.
  • BD
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES, INC.
  • QIAGEN

 

1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          In-Vitro Diagnostics Market – By Product and Services

1.3.2          In-Vitro Diagnostics Market – By Technology

1.3.3          In-Vitro Diagnostics Market – By Application

1.3.4          In-Vitro Diagnostics Market – By End User

1.3.5          Middle East and Africa In-Vitro Diagnostics Market – By Country

2.           Middle East and Africa In-Vitro Diagnostics Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           Middle East and Africa In-Vitro Diagnostics Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          In-Vitro Diagnostics Market- Middle East and Africa PEST Analysis

4.3          Expert Opinion

5.           Middle East and Africa In-Vitro Diagnostics Market - Key Market Dynamics

5.1          Market Drivers

5.1.1          Increasing Prevalence of Chronic and Infectious Diseases

5.1.2          Growing Geriatric Population

5.1.3          Rising Demand for In-Vitro Diagnostics During COVID-19 Pandemic

5.2          Market Restraints

5.2.1          Lack of Healthcare Infrastructure and Reimbursement Policies

5.3          Future Trends

5.3.1          Increasing Adoption and Popularity of Automation in Clinical Laboratories

5.4          Impact Analysis

6.           In-Vitro Diagnostics Market – Middle East and Africa Analysis

6.1          Middle East and Africa In-Vitro Diagnostics Market Revenue Forecasts and Analysis

7.           Middle East and Africa In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Product and Services

7.1          Overview

7.2          In-Vitro Diagnostics, by Product and Services, 2019 & 2027 (% Share)

7.3          Reagents & Kits

7.3.1          Overview

7.3.2          Reagents & Kits Market Revenue and Forecast to 2027 (US$ Mn)

7.4          Instruments

7.4.1          Overview

7.4.2          Instruments Market Revenue and Forecast to 2027 (US$ Mn)

7.5          Software & Services

7.5.1          Overview

7.5.2          Software & Services Market Revenue and Forecast to 2027 (US$ Mn)

8.           Middle East and Africa In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Technology

8.1          Overview

8.2          In-Vitro Diagnostics Market, by Technology, 2019 & 2027 (% Share)

8.3          Immunoassay/Immunochemistry

8.3.1          Overview

8.3.2          Immunoassay/Immunochemistry Market Revenue and Forecast to 2027 (US$ Mn)

8.4          Clinical Chemistry

8.4.1          Overview

8.4.2          Clinical Chemistry Market Revenue and Forecast to 2027 (US$ Mn)

8.5          Molecular Diagnostics

8.5.1          Overview

8.5.2          Molecular Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

8.6          Microbiology

8.6.1          Overview

8.6.2          Microbiology Market Revenue and Forecast to 2027 (US$ Mn)

8.7          Blood Glucose Self-Monitoring

8.7.1          Overview

8.7.2          Blood Glucose Self-Monitoring Market Revenue and Forecast to 2027 (US$ Mn)

8.8          Coagulation and Hemostasis

8.8.1          Overview

8.8.2          Coagulation and Hemostasis Market Revenue and Forecast to 2027 (US$ Mn)

8.9          Haematology

8.9.1          Overview

8.9.2          Haematology Market Revenue and Forecast to 2027 (US$ Mn)

8.10        Urinalysis

8.10.1        Overview

8.10.2        Urinalysis Market Revenue and Forecast to 2027 (US$ Mn)

8.11        Others

8.11.1        Overview

8.11.2        Others Market Revenue and Forecast to 2027 (US$ Mn)

9.           Middle East and Africa In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Application

9.1          Overview

9.2          In-Vitro Diagnostics Market, by Application, 2019 & 2027 (% Share)

9.3          Infectious Diseases

9.3.1          Overview

9.3.2          Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)

9.4          Diabetes

9.4.1          Overview

9.4.2          Diabetes Market Revenue and Forecast to 2027 (US$ Mn)

9.5          Oncology

9.5.1          Overview

9.5.2          Oncology Market Revenue and Forecast to 2027 (US$ Mn)

9.6          Cardiology

9.6.1          Overview

9.6.2          Cardiology Market Revenue and Forecast to 2027 (US$ Mn)

9.7          Autoimmune Disease

9.7.1          Overview

9.7.2          Autoimmune Disease Market Revenue and Forecast to 2027 (US$ Mn)

9.8          Nephrology

9.8.1          Overview

9.8.2          Nephrology Market Revenue and Forecast to 2027 (US$ Mn)

9.9          Others

9.9.1          Overview

9.9.2          Others Market Revenue and Forecast to 2027 (US$ Mn)

10.        Middle East and Africa In-Vitro Diagnostics Market Analysis and Forecasts to 2027– By End user

10.1        Overview

10.2        In-Vitro Diagnostics Market Share by End User 2019 & 2027 (%)

10.3        Hospitals

10.3.1        Overview

10.3.2        Hospitals Market Revenue and Forecast to 2027 (US$ Mn)

10.4        Laboratories

10.4.1        Overview

10.4.2        Laboratories Market Revenue and Forecast to 2027 (US$ Mn)

10.5        Homecare

10.5.1        Overview

10.5.2        Homecare Market Revenue and Forecast to 2027 (US$ Mn)

10.6        Others

10.6.1        Overview

10.6.2        Others Market Revenue and Forecast to 2027 (US$ Mn)

11.        In-Vitro Diagnostics Market Revenue and Forecasts to 2027 – Geographical Analysis

11.1        Middle East and Africa In-Vitro Diagnostics Market Revenue And Forecast To 2027

11.1.1        Middle East and Africa In-Vitro Diagnostics Market Revenue and Forecast to 2027, By Country (%)

11.1.2        Saudi Arabia

11.1.2.1          Saudi Arabia In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.2.1.1           Saudi Arabia In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product and Services (US$ Mn)

11.1.2.1.2           Saudi Arabia In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.2.1.3           Saudi Arabia In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.2.1.4           Saudi Arabia In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

11.1.3        South Africa

11.1.3.1          South Africa In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.3.1.1           South Africa In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product and Services (US$ Mn)

11.1.3.1.2           South Africa In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.3.1.3           South Africa In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.3.1.4           South Africa In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

11.1.4        UAE

11.1.4.1          UAE In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.4.1.1           UAE In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product and Services (US$ Mn)

11.1.4.1.2           UAE In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.4.1.3           UAE In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.4.1.4           UAE In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

11.1.5        Rest of Middle East and Africa

11.1.5.1          Rest of Middle East and Africa In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.5.1.1           Rest of Middle East and Africa In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product and Services (US$ Mn)

11.1.5.1.2           Rest of Middle East and Africa In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.5.1.3           Rest of Middle East and Africa In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application  (US$ Mn)

11.1.5.1.4           Rest of Middle East and Africa In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

12.        Impact Of COVID-19 Pandemic on Middle East and Africa In-Vitro Diagnostics Market

12.1        Middle East and Africa: Impact Assessment of COVID-19 Pandemic

13.        Industry Landscape

13.1        Overview

13.2        Organic Developments Done by The Companies in The Market

13.3        Inorganic Developments Done by The Companies in The Market

14.        COMPANY PROFILES

14.1        Abbott

14.1.1        Key Facts

14.1.2        Business Description

14.1.3        Products and Services

14.1.4        Financial Overview

14.1.5        SWOT Analysis

14.1.6        Key Developments

14.2        F. HOFFMANN-LA ROCHE LTD.

14.2.1        Key Facts

14.2.2        Business Description

14.2.3        Products and Services

14.2.4        Financial Overview

14.2.5        SWOT Analysis

14.2.6        Key Developments

14.3        Danaher

14.3.1        Key Facts

14.3.2        Business Description

14.3.3        Products and Services

14.3.4        Financial Overview

14.3.5        SWOT Analysis

14.3.6        Key Developments

14.4        Siemens AG

14.4.1        Key Facts

14.4.2        Business Description

14.4.3        Products and Services

14.4.4        Financial Overview

14.4.5        SWOT Analysis

14.4.6        Key Developments

14.5        Sysmex Corporation

14.5.1        Key Facts

14.5.2        Business Description

14.5.3        Products and Services

14.5.4        Financial Overview

14.5.5        SWOT Analysis

14.5.6        Key Developments

14.6        THERMO FISHER SCIENTIFIC INC.

14.6.1        Key Facts

14.6.2        Business Description

14.6.3        Products and Services

14.6.4        Financial Overview

14.6.5        SWOT Analysis

14.6.6        Key Developments

14.7        BD

14.7.1        Key Facts

14.7.2        Business Description

14.7.3        Products and Services

14.7.4        Financial Overview

14.7.5        SWOT Analysis

14.7.6        Key Developments

14.8        bioMerieux SA

14.8.1        Key Facts

14.8.2        Business Description

14.8.3        Products and Services

14.8.4        Financial Overview

14.8.5        SWOT Analysis

14.8.6        Key Developments

14.9        BIO-RAD LABORATORIES INC.

14.9.1        Key Facts

14.9.2        Business Description

14.9.3        Products and Services

14.9.4        Financial Overview

14.9.5        SWOT Analysis

14.9.6        Key Developments

14.10     QIAGEN

14.10.1      Key Facts

14.10.2      Business Description

14.10.3      Products and Services

14.10.4      Financial Overview

14.10.5      SWOT Analysis

14.10.6      Key Developments

15.        Appendix

15.1        About the Insight Partners

15.2        Glossary of Terms

 

LIST OF TABLES

Table 1.              Key launches 2016: By Roche

Table 2.              Saudi Arabia In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product and Services (US$ Mn)

Table 3.              Saudi Arabia In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 4.              Saudi Arabia In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 5.              Saudi Arabia In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 6.              South Africa In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product and Services (US$ Mn)

Table 7.              South Africa In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 8.              South Africa In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 9.              South Africa In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 10.            UAE In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product and Services (US$ Mn)

Table 11.            UAE In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 12.            UAE In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 13.            UAE In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 14.            Rest of Middle East and Africa In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product and Services (US$ Mn)

Table 15.            Rest of Middle East and Africa In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 16.            Rest of Middle East and Africa In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 17.            Rest of Middle East and Africa In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 18.            Organic Developments Done by The Companies

Table 19.            Inorganic Developments Done by The Companies

Table 20.            Glossary of Terms, In-Vitro Diagnostics Market

 

LIST OF FIGURES

Figure 1.            In-Vitro Diagnostics Market Segmentation

Figure 2.            Middle East and Africa In-Vitro Diagnostics Market Overview

Figure 3.            Reagents and Kits Segment Held Largest Share of Product and Services in In-Vitro Diagnostics Market

Figure 4.            Infectious Diseases Segment Held Largest Share of Application in In-Vitro Diagnostics Market

Figure 5.            UAE is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.            In-Vitro Diagnostics Market - Middle East and Africa PEST Analysis

Figure 7.            In-Vitro Diagnostics Market Impact Analysis of Driver and Restraints

Figure 8.            Middle East and Africa In-Vitro Diagnostics Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.            In-Vitro Diagnostics, by Product and Services, 2019 & 2027 (% Share)

Figure 10.          Reagents & Kits Market Revenue and Forecast to 2027 (US$ Mn)

Figure 11.          Instruments Market Revenue and Forecast to 2027 (US$ Mn)

Figure 12.          Software & Services Market Revenue and Forecast to 2027 (US$ Mn)

Figure 13.          In-Vitro Diagnostics Market, By Technology, 2019 & 2027 (% Share)

Figure 14.          Immunoassay/Immunochemistry Market Revenue And Forecast To 2027 (US$ Mn)

Figure 15.          Clinical Chemistry Market Revenue And Forecast To 2027 (US$ Mn)

Figure 16.          Molecular Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 17.          Microbiology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 18.          Blood Glucose Self-Monitoring Market Revenue And Forecast To 2027 (US$ Mn)

Figure 19.          Coagulation and Hemostasis Market Revenue And Forecast To 2027 (US$ Mn)

Figure 20.          Hematology Market Revenue and Forecast to 2027 (US$ Mn)

Figure 21.          Urinalysis Market Revenue And Forecast To 2027 (US$ Mn)

Figure 22.          Others Market Revenue And Forecast To 2027 (US$ Mn)

Figure 23.          In-Vitro Diagnostics Market, By Application, 2019 & 2027 (% Share)

Figure 24.          Infectious Diseases Market Revenue And Forecast To 2027 (US$ Mn)

Figure 25.          Diabetes Market Revenue And Forecast To 2027 (US$ Mn)

Figure 26.          Most Prevalent Forms of Cancers Globally, 2018

Figure 27.          Oncology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 28.          Cardiology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 29.          Autoimmune Disease Market Revenue And Forecast To 2027 (US$ Mn)

Figure 30.          Nephrology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 31.          Others Market Revenue And Forecast To 2027 (US$ Mn)

Figure 32.          In-Vitro Diagnostics Market Share by End User 2019 & 2027 (%)

Figure 33.          Hospitals Market Revenue And Forecast To 2027 (US$ Mn)

Figure 34.          Laboratories Market Revenue And Forecast To 2027 (US$ Mn)

Figure 35.          Homecare Market Revenue And Forecast To 2027 (US$ Mn)

Figure 36.          Others Market Revenue and Forecast to 2027 (US$ Mn)

Figure 37.          Middle East and Africa In-Vitro Diagnostics Market Revenue, By Country, 2019 (US$ Mn)

Figure 38.          Middle East and Africa In-Vitro Diagnostics Market Revenue and Forecast to 2027, By Country (%)

Figure 39.          Saudi Arabia In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 40.          South Africa In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 41.          UAE In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 42.          Rest of Middle East and Africa In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 43.          Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 44.          Growth Strategies Done by the Companies in the Market, (%)

 

 

  1. F. HOFFMANN-LA ROCHE LTD.
  2. DANAHER
  3. ABBOTT
  4. SIEMENS AG
  5. SYSMEX CORPORATION
  6. THERMO FISHER SCIENTIFIC, INC.
  7. BD
  8. BIOMERIEUX SA
  9. BIO-RAD LABORATORIES, INC.
  10. QIAGEN
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa In-vitro diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa In-vitro diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Middle East and Africa market trends and outlook coupled with the factors driving the in-vitro diagnostics market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
TIPRE00022124
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing